Magnesium Deficiency: Why 50% of People Are Low and How to Fix It Through Food

A landmark analysis by Rosanoff and colleagues found that US dietary magnesium intake declined significantly over the 20th century, driven by shifts toward ultra-processed foods, a reduction in whole grain consumption and intensive agricultural practices that have depleted soil magnesium levels (PMID: 22364157). Modern food processing strips magnesium from grains — white flour retains only about 20% of the magnesium present in whole wheat. Simultaneously, higher sugar and alcohol intake increase urinary magnesium excretion. The result is a population chronically under-consuming a mineral that every cell in the body depends upon.

Mild magnesium deficiency often presents without obvious symptoms, as the body draws on bone stores to maintain serum levels — making blood tests unreliable for detecting subclinical deficiency. When deficiency deepens, the most common symptoms include muscle cramps, twitching and spasms (particularly at night), fatigue and low energy, poor sleep quality, increased anxiety, headaches and migraines, irregular heartbeat and constipation. Because these symptoms are non-specific, magnesium deficiency is frequently missed or attributed to other causes. A trial of magnesium repletion through diet or supplementation is often the most practical diagnostic approach.

One of the most clinically significant consequences of low magnesium is its effect on glucose metabolism. Magnesium is required for insulin receptor signalling — specifically, for the autophosphorylation of the insulin receptor tyrosine kinase. Guerrero-Romero and Rodríguez-Morán demonstrated in a controlled trial that magnesium supplementation (382 mg per day for 16 weeks) improved insulin sensitivity and beta-cell function in people with type 2 diabetes (PMID: 21241290). Epidemiological studies consistently show an inverse relationship between dietary magnesium intake and type 2 diabetes risk, with each 100 mg increase in daily intake associated with approximately a 15% lower risk.

Zhang and colleagues conducted a dose-response meta-analysis of 34 randomised controlled trials and found that magnesium supplementation at doses of 300–450 mg per day produced significant reductions in both systolic and diastolic blood pressure (PMID: 27402922). The effect was most pronounced in people who were already hypertensive and those with lower baseline magnesium status. Magnesium relaxes vascular smooth muscle by antagonising calcium-mediated contraction — the same mechanism exploited by calcium channel blocker medications. Achieving adequate dietary magnesium may therefore be an underutilised tool in blood pressure management.

Magnesium's role in sleep is mediated through multiple mechanisms: it activates the parasympathetic nervous system, regulates melatonin production and binds to GABA receptors — the same receptors targeted by sleep medications. Abbasi and colleagues conducted a randomised double-blind trial in elderly individuals with insomnia and found that 500 mg of magnesium supplementation for 8 weeks significantly improved sleep onset time, sleep duration, early morning awakening and serum melatonin levels (PMID: 23853635). Older adults are particularly vulnerable to both magnesium deficiency and sleep disruption, making magnesium repletion an especially valuable intervention in this population.

The richest dietary sources of magnesium include dark leafy greens (spinach, Swiss chard, kale), legumes (black beans, edamame, lentils), nuts and seeds (pumpkin seeds at 168 mg per 30 g are particularly exceptional), whole grains (quinoa, oats, brown rice), dark chocolate and oily fish like mackerel. An adult requires 310–420 mg per day depending on age and sex. A diet centred on whole plant foods, with generous portions of leafy greens, legumes and seeds, can comfortably meet this requirement. The key barrier for most people is the displacement of these foods by ultra-processed alternatives with negligible magnesium content.

Supplementation is a practical strategy for people who struggle to meet magnesium requirements through diet alone, those with gastrointestinal conditions affecting absorption, or those taking medications (diuretics, proton pump inhibitors) that increase urinary magnesium loss. The most bioavailable supplemental forms are magnesium glycinate, magnesium malate and magnesium citrate. Magnesium oxide, despite being the most common form, has poor bioavailability around 4%. Doses of 200–400 mg of elemental magnesium per day are generally well-tolerated; higher doses may cause loose stools. The upper tolerable intake level from supplements is set at 350 mg per day for adults — amounts above this should be discussed with a healthcare provider.

Beyond poor dietary intake, several lifestyle and physiological factors accelerate magnesium depletion. Chronic psychological stress increases urinary magnesium excretion via cortisol-driven mechanisms. High alcohol intake is strongly associated with hypomagnesaemia. Intense physical exercise increases magnesium losses through sweat and urine — athletes may require 10–20% more than the standard RDA. Coffee and other caffeine sources modestly increase urinary excretion. Type 2 diabetes is associated with both lower intake and higher renal losses of magnesium, creating a vicious cycle. Awareness of these depletion factors helps identify who is at greatest risk and in most need of attention.